Blinatumomab shows superior survival than conventional chemotherapy in paediatric patients with B-cell precursor acute lymphoblastic leukaemia, a 5-year follow-up analysis of a trial shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/blinatumomab-shows-sustained-long-term-benefits-paediatric-2025a1000wch?src=rss
Author :
Publish date : 2025-11-24 12:00:00
Copyright for syndicated content belongs to the linked Source.
